Page last updated: 2024-09-25

quinapyramine

Description

quinapyramine: RN given refers to hydride; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122993
CHEMBL ID1398609
SCHEMBL ID291197
SCHEMBL ID14286196
MeSH IDM0047436

Synonyms (30)

Synonym
nsc-48223
NCI60_004145
n6-(2-imino-1,6-dimethyl-1,2-dihydro-4-pyrimidinyl)-1,2-dimethyl-15-quinoline-4,6-diamine
antrycide
quinolinium, 4-amino-6-[(2-amino-1,6-dimethyl-4(1h)-pyrimidinylidene)amino]-1,2-dimethyl-
23609-65-6
6-[(e)-(2-amino-1,6-dimethyl-pyrimidin-4-ylidene)amino]-1,2-dimethyl-quinolin-1-ium-4-amine
quinapyramine
NSC48223 ,
NCGC00013591
NCI48223
4-amino-6-((2-amino-1,6-dimethyl-4-pyrimidinyl)amino)-1-methylquinaldinium ion
quinolinium, 4-amino-6-((2-amino-1,6-dimethyl-4(1h)-pyrimidinylidene)amino)-1,2-dimethyl-, conjugate monoacid
NCISTRUC2_001482
NCISTRUC1_001223
NCGC00096704-01
CCG-36923
NCGC00013591-02
quinapyramine cation
20493-41-8
quinapyramine ion
b2nt1100wr ,
unii-b2nt1100wr
quinolinium, 4-amino-6-((1,2-dihydro-2-imino-1,6-dimethyl-4-pyrimidinyl)amino)-1,2-dimethyl-
quinapyramine [mi]
1082114-38-2
SCHEMBL291197
SCHEMBL14286196
CHEMBL1398609
6-[(2-amino-1,6-dimethylpyrimidin-4-ylidene)amino]-1,2-dimethylquinolin-1-ium-4-amine

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
15-lipoxygenase, partialHomo sapiens (human)Potency7.94330.012610.691788.5700AID887
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency0.79430.28189.721235.4813AID2326
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (80)

TimeframeStudies, This Drug (%)All Drugs %
pre-199050 (62.50)18.7374
1990's13 (16.25)18.2507
2000's5 (6.25)29.6817
2010's10 (12.50)24.3611
2020's2 (2.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.70%)6.00%
Case Studies1 (1.23%)4.05%
Observational0 (0.00%)0.25%
Other77 (95.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (2)

ArticleYear
Cytotoxicity and genotoxicity of a trypanocidal drug quinapyramine sulfate loaded-sodium alginate nanoparticles in mammalian cells.
International journal of biological macromolecules, Volume: 88
2016
In vitro activity and preliminary toxicity of various diamidine compounds against Trypanosoma evansi.
Veterinary parasitology, May-11, Volume: 169, Issue: 3-4
2010
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (1)

ArticleYear
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Acta tropica, Volume: 50, Issue: 2
1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (5)

ArticleYear
Studies of quinapyramine-resistance of Trypanosoma brucei evansi in China.
Acta tropica, Volume: 116, Issue: 3
2010
Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France.
Veterinary parasitology, Jun-10, Volume: 162, Issue: 3-4
2009
Resistance to drug by different isolates Trypanosoma evansi in China.
Acta tropica, Volume: 90, Issue: 3
2004
Drug resistance in Sudanese Trypanosoma evansi.
Veterinary parasitology, Jan-28, Volume: 80, Issue: 4
1999
In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
Acta tropica, Volume: 50, Issue: 2
1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]